Delivery Order SPE2DB20D1109-SPE2DB24FN54F

Award Date 2/1/24
Potential Completion Date 2/23/24
Potential Value $26K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,310.60 fixed-price delivery order is for the supply of XEOMIN 100 unit vials, with a completion date of November 12, 2024. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,484.80 firm fixed-price delivery order is for the supply of 4,565,867,752 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,558.24 firm fixed-price delivery order is for the supply of 4,566,604,207 units of the medication XEOMIN 200 UNIT VIALS. The contract has an ultimate completion date of December 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,135.40 firm-fixed-price delivery order is for the supply of 4,566,604,209 units of XEOMIN 200 unit vials. The contract has an ultimate completion date of December 24, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of XEOMIN 50 unit vials to the agency. The $3,562.50 firm-fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which covers a comprehensive range of...
This federal contract award, valued at $41,905.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the procurement of 4,567,030,914 units of XEOMIN 200 UNIT VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $39,111.80 firm fixed-price delivery order is for the supply of 4,567,495,026 units of XEOMIN 200 unit vials. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,524.96 firm fixed-price delivery order is for the supply of 4,566,604,212 units of XEOMIN 200 unit vials. The award date is December 2, 2024, with an ultimate completion date of December 23, 2024. This contract does not have a set-aside designation, indicating open competition. As a key vendor for federal...
This federal contract award, valued at $6,290.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4559789206 units of XEOMIN 200-unit vials, a pharmaceutical product, to support military healthcare programs. The contract is a delivery order awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, valued at $1,179.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,738,226 units of XEOMIN 50 unit vials. The contract is a Firm Fixed Price Delivery Order that runs through January 7, 2025. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FN54F
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,212.50 firm fixed-price delivery order is for the procurement of 4,563,523,345 units of XEOMIN 200 unit vials. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen's parent company, Cencora, Inc., also maintains a separate IDC valued at up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contract vehicles enable the efficient government procurement of essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:57 AM